Imugene Limited is a biotechnology company developing immunotherapies for cancer treatment, focusing on harnessing the body’s immune system to target and eradicate tumors.
Ticker code: IMU
Sector: Healthcare | Industry: Biotechnology | Website: https://www.imugene.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $110,488,664 | $81,035,896 | 320256978.0 | 74.27 | $82,063,425 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $65,652,678 | $21,935,432 | $10,651,476 | None | None | -17.2 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Positive | 8.9 | $255,652 | $796,855 | None | 0.0 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | None |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $0.345 | -1.4 | 4.5 | 6.2 | 27.8 | -36.6 | -73.3 |
IMU Price Chart with Volume and 3EMA
IMU Short Positions
Click HERE to understand why the above moving averages have been chosen.